Insider Trading activities of Biogen Idec Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biogen Idec Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biogen Idec Inc since year 2005. Table 2 shows the detailed insider transactions of Biogen Idec Inc since 2005. The reporting company's ticker symbol is BIIB. The reporting company's CIK number is 875045.
The total value of stock buying since 2005 is $89,143,516.
The total value of stock sales since 2005 is $569,589,441.
The total value of stock option exercises since 2005 is $243,892,560.


Go to page:  1   2   3   4   5 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Biogen Idec Inc (BIIB).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-01 0 $0 5,450 $1,609,875 5,450 $284,599
2016-10 0 $0 642 $200,668 1,982 $0
2016-09 0 $0 27,570 $8,656,980 27,570 $1,478,854
2016-07 0 $0 157 $43,960 0 $0
2016-06 0 $0 1,884 $545,371 1,643 $0
2016-05 0 $0 4,012 $1,154,478 348 $0
2016-04 0 $0 746 $198,060 975 $0
2016-02 0 $0 1,339 $334,801 23,960 $674,327
2015-12 0 $0 489 $136,035 0 $0
2015-10 310,000 $86,015,000 686 $196,563 1,939 $0
2015-07 10,000 $3,048,780 0 $0 0 $0
2015-06 0 $0 6,073 $2,467,776 2,384 $0
2015-05 0 $0 0 $0 347 $134,018
2015-04 0 $0 1,362 $576,398 975 $0
2015-03 0 $0 50,737 $22,218,234 38,024 $2,272,494
2015-02 0 $0 8,751 $3,429,901 126,498 $0
2014-12 0 $0 4,170 $1,425,654 0 $0
2014-11 0 $0 2,878 $939,339 0 $0
2014-10 0 $0 2,877 $952,200 0 $0
2014-09 0 $0 1,128 $389,690 0 $0
2014-08 0 $0 1,128 $375,545 0 $0
2014-07 0 $0 12,316 $3,847,148 21,339 $0
2014-06 0 $0 1,789 $562,287 0 $0
2014-05 0 $0 3,344 $959,374 347 $99,502
2014-04 0 $0 9,594 $2,937,711 7,225 $297,187
2014-03 0 $0 60,391 $20,293,175 10,000 $536,400
2014-02 0 $0 10,242 $3,244,082 124,514 $0
2014-01 0 $0 29,770 $8,473,567 11,750 $626,197
2013-12 0 $0 1,439 $417,220 0 $0
2013-11 0 $0 7,239 $1,946,831 4,000 $199,800
2013-10 0 $0 18,269 $4,545,714 15,030 $910,216
2013-09 0 $0 147,715 $35,366,137 139,635 $7,139,412
2013-08 0 $0 6,607 $1,413,105 0 $0
2013-07 0 $0 2,239 $501,401 21,339 $0
2013-06 0 $0 23,363 $5,316,417 12,825 $767,191
2013-05 0 $0 83,448 $19,957,228 82,297 $4,378,588
2013-04 0 $0 25,210 $5,567,807 0 $0
2013-03 0 $0 65,153 $11,278,033 46,675 $2,672,470
2013-02 0 $0 14,098 $2,330,472 97,238 $662,225
2012-12 0 $0 7,980 $1,186,713 0 $0
2012-11 0 $0 2,472 $344,292 0 $0
2012-10 0 $0 3,654 $545,030 0 $0
2012-09 0 $0 15,654 $2,349,918 10,000 $662,900
2012-08 0 $0 4,820 $701,309 0 $0
2012-07 0 $0 61,725 $9,241,270 79,409 $3,199,947
2012-06 0 $0 79,451 $10,996,322 74,700 $3,581,309
2012-05 0 $0 34,455 $4,651,425 25,975 $1,213,843
2012-04 0 $0 20,000 $2,600,000 20,000 $894,599
2012-03 0 $0 7,500 $900,000 7,500 $267,300
2012-02 0 $0 43,865 $5,217,717 94,998 $1,578,049
2012-01 0 $0 43,236 $4,941,631 22,992 $1,336,881
2011-12 0 $0 3,295 $366,486 0 $0
2011-11 0 $0 2,971 $337,937 2,175 $158,492
2011-10 0 $0 1,030 $96,613 778 $38,581
2011-09 0 $0 71,335 $6,830,155 68,250 $3,329,739
2011-08 0 $0 25,000 $2,313,670 25,000 $1,752,200
2011-07 0 $0 15,248 $1,625,910 21,341 $0
2011-06 0 $0 2,300 $213,021 0 $0
2011-05 0 $0 96,325 $9,091,228 74,150 $4,218,349
2011-04 0 $0 104,475 $9,009,387 99,525 $5,526,198
2011-03 0 $0 22,044 $1,545,212 37,840 $2,129,814
2011-02 0 $0 16,548 $1,120,825 29,904 $531,870
2011-01 0 $0 11,353 $768,571 10,557 $511,117
2010-12 0 $0 65,246 $4,397,431 79,450 $4,063,778
2010-11 0 $0 1,538 $96,823 0 $0
2010-10 0 $0 21,900 $1,394,700 21,900 $1,123,143
2010-08 177 $9,984 9,542 $542,548 0 $0
2010-07 368 $19,922 0 $0 0 $0
2010-06 408 $19,945 2,900 $138,102 0 $0
2010-05 403 $19,904 0 $0 0 $0
2010-04 187 $9,981 5,668 $295,795 0 $0
2010-03 0 $0 448,840 $26,904,701 440,500 $22,068,966
2010-02 0 $0 13,133 $737,490 0 $0
2010-01 0 $0 1,389 $76,395 0 $0
2009-12 0 $0 162,037 $8,160,536 15,000 $466,245
2009-11 0 $0 2,854 $122,208 1,000 $0
2009-09 0 $0 15,000 $780,000 15,000 $466,245
2009-06 0 $0 5,714 $282,805 0 $0
2009-04 0 $0 17,398 $948,191 0 $0
2009-02 0 $0 50,080 $2,565,853 51,897 $0
2009-01 0 $0 340 $16,466 3,333 $0
2008-11 0 $0 3,700 $165,057 1,000 $0
2008-10 0 $0 2,047 $102,350 0 $0
2008-09 0 $0 2,287 $114,350 0 $0
2008-08 0 $0 568 $28,777 0 $0
2008-07 0 $0 343,119 $23,401,076 294,409 $41,408,916
2008-06 0 $0 1,840 $113,384 0 $0
2008-04 0 $0 1,615,272 $104,385,887 915,844 $37,296,955
2008-02 0 $0 75,110 $4,591,943 100,385 $1,392,918
2008-01 0 $0 0 $0 3,333 $0
2007-12 0 $0 69,569 $3,974,036 43,119 $1,875,676
2007-11 0 $0 0 $0 1,000 $0
2007-10 0 $0 350,995 $28,781,590 350,995 $20,143,338
2007-09 0 $0 66,639 $4,331,535 66,639 $3,820,613
2007-08 0 $0 146,231 $9,219,893 146,231 $6,821,052
2007-07 0 $0 449,290 $25,508,602 448,557 $19,025,814
2007-06 0 $0 33,102 $1,745,635 27,277 $1,070,562
2007-05 0 $0 50,815 $2,549,092 55,619 $1,449,391
2007-04 0 $0 78,747 $3,749,434 63,737 $2,370,543
2007-03 0 $0 46,084 $2,047,586 5,000 $176,850
2007-02 0 $0 75,498 $3,720,485 89,105 $176,850
2007-01 0 $0 31,176 $1,583,991 33,157 $358,479
2006-11 0 $0 497,800 $25,087,615 497,800 $17,775,784
2006-10 0 $0 77,488 $3,521,540 66,244 $874,581
2006-09 0 $0 113,791 $4,878,716 6,900 $104,604
2006-07 0 $0 109,000 $4,543,202 109,000 $1,354,760
2006-05 0 $0 0 $0 1,250 $0
2006-04 0 $0 58,675 $2,650,851 58,675 $588,329
2006-03 0 $0 10,350 $485,963 10,350 $156,906
2006-01 0 $0 118,420 $5,230,413 103,500 $3,050,145
2005-12 0 $0 20,500 $914,915 20,500 $346,449
2005-07 0 $0 80,000 $2,897,600 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Biogen Idec Inc insiders (BIIB)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-01-09 Pangia Robert W (Director) Sale 5,450 295.39 1,609,875
2017-01-09 Pangia Robert W (Director) Option Ex 5,450 52.22 284,599
2016-10-04 Karaboutis Adriana (EVP, Tech, Bus. Sol & Corp Aff) Sale 262 311.94 81,728
2016-10-03 Karaboutis Adriana (EVP, Tech, Bus. Sol & Corp Aff) Sale 380 313.00 118,940
2016-10-01 Karaboutis Adriana (EVP, Tech, Bus. Sol & Corp Aff) Option Ex 1,982 .00 0
2016-09-22 Dorsa Caroline (Director) Sale 27,570 314.00 8,656,980
2016-09-22 Dorsa Caroline (Director) Option Ex 27,570 53.64 1,478,854
2016-07-21 Scangos George A (Chief Executive Officer) Sale 157 280.00 43,960
2016-06-06 Koppel Adam (EVP, Strategy and Bus. Dev.) Sale 555 290.00 160,950
2016-06-03 Scangos George A (Chief Executive Officer) Sale 842 290.00 244,180
2016-06-02 Koppel Adam (EVP, Strategy and Bus. Dev.) Option Ex 1,643 .00 0
2016-06-01 Scangos George A (Chief Executive Officer) Sale 487 287.97 140,241
2016-05-31 Scangos George A (Chief Executive Officer) Sale 3,368 290.00 976,720
2016-05-25 Scangos George A (Chief Executive Officer) Sale 157 280.00 43,960
2016-05-02 Scangos George A (Chief Executive Officer) Sale 487 274.74 133,798
2016-05-01 Covino Gregory F (VP, Chief Accounting Officer) Option Ex 348 .00 0
2016-04-06 Koppel Adam (EVP, Strategy and Bus. Dev.) Sale 102 275.00 28,050
2016-04-06 Scangos George A (Chief Executive Officer) Sale 157 280.00 43,960
2016-04-02 Artavanis-tsakonas Spyridon (EVP, Chief Scientific Officer) Option Ex 975 .00 0
2016-04-01 Scangos George A (Chief Executive Officer) Sale 487 258.83 126,050
2016-02-17 Scangos George A (Chief Executive Officer) Sale 487 256.16 124,749
2016-02-12 Artavanis-tsakonas Spyridon (SVP, Chief Scientific Officer) Option Ex 1,057 .00 0
2016-02-12 Clancy Paul J (Executive VP and CFO) Option Ex 3,859 .00 0
2016-02-09 Sandrock Alfred (EVP CMO Neuro & Neurodegenerat) Sale 852 246.54 210,052
2016-02-09 Scangos George A (Chief Executive Officer) Option Ex 11,274 .00 0
2016-02-08 Sandrock Alfred (EVP CMO Neuro & Neurodegenerat) Option Ex 1,278 .00 0
2016-02-08 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 4,026 .00 0
2016-02-01 Dipietro Kenneth (EVP Human Resources) Option Ex 2,466 273.45 674,327
2015-12-04 Sandrock Alfred (EVP CMO Neuro & Neurodegenerat) Sale 441 277.00 122,157
2015-12-02 Karaboutis Adriana (EVP, Tech. and Bus. Solutions) Sale 48 289.14 13,878
2015-10-23 Denner Alexander J (Director) Buy 100,000 276.77 27,677,000
2015-10-22 Denner Alexander J (Director) Buy 210,000 277.80 58,338,000
2015-10-05 Karaboutis Adriana (EVP, Tech. and Bus. Solutions) Sale 269 291.43 78,394
2015-10-02 Karaboutis Adriana (EVP, Tech. and Bus. Solutions) Sale 417 283.38 118,169
2015-10-01 Karaboutis Adriana (EVP, Tech. and Bus. Solutions) Option Ex 1,939 .00 0
2015-07-27 Papadopoulos Stelios (Director) Buy 10,000 304.88 3,048,780
2015-06-22 Posner Brian S (Director) Sale 470 415.00 195,050
2015-06-19 Williams Douglas E (EVP Research & Development) Sale 3,841 410.00 1,574,810
2015-06-15 Posner Brian S (Director) Sale 400 386.64 154,656
2015-06-02 Koppel Adam (SVP, Chief Strategy Officer) Option Ex 2,384 .00 0
2015-06-01 Scangos George A (Chief Executive Officer) Sale 1,362 398.87 543,260
2015-05-01 Covino Gregory F (VP, Chief Accounting Officer) Option Ex 347 386.22 134,018
2015-04-02 Artavanis-tsakonas Spyridon (SVP, Chief Scientific Officer) Option Ex 975 .00 0
2015-04-01 Scangos George A (Chief Executive Officer) Sale 1,362 423.20 576,398
2015-03-27 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 430 430.12 184,951
2015-03-25 Cox John (EVP Pharmaceutical Oper & Tech) Sale 12,010 449.06 5,393,210
2015-03-25 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 5,066 66.72 337,978
2015-03-20 Rowinsky Eric K (Director) Sale 11,667 475.00 5,541,825
2015-03-20 Rowinsky Eric K (Director) Option Ex 11,667 59.82 697,919
2015-03-19 Rowinsky Eric K (Director) Sale 2,333 436.14 1,017,507
2015-03-19 Rowinsky Eric K (Director) Option Ex 2,333 59.82 139,560
2015-03-17 Rowinsky Eric K (Director) Sale 4,667 425.45 1,985,589
2015-03-17 Rowinsky Eric K (Director) Option Ex 4,667 59.82 279,179
2015-03-16 Dipietro Kenneth (EVP Human Resources) Sale 803 415.46 333,614
2015-03-13 Scangos George A (Chief Executive Officer) Sale 537 412.69 221,613
2015-03-10 Pangia Robert W (Director) Sale 3,625 413.23 1,497,958
2015-03-10 Pangia Robert W (Director) Option Ex 3,625 49.60 179,818
2015-03-10 Sherwin Stephen A (Director) Sale 6,000 409.67 2,458,020
2015-03-10 Sherwin Stephen A (Director) Option Ex 6,000 59.82 358,920
2015-03-09 Rowinsky Eric K (Director) Sale 4,666 417.23 1,946,795
2015-03-09 Rowinsky Eric K (Director) Option Ex 4,666 59.82 279,120
2015-03-02 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 3,174 409.06 1,298,350
2015-03-02 Scangos George A (Chief Executive Officer) Sale 825 410.67 338,802
2015-02-19 Scangos George A (Chief Executive Officer) Sale 537 401.04 215,358
2015-02-17 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 418 389.11 162,647
2015-02-17 Dipietro Kenneth (EVP Human Resources) Sale 1,188 389.11 462,262
2015-02-17 Holtzman Steven H (EVP Corporate Development) Sale 2,128 389.11 828,026
2015-02-17 Scangos George A (Chief Executive Officer) Sale 825 389.11 321,015
2015-02-12 Artavanis-tsakonas Spyridon (SVP, Chief Scientific Officer) Option Ex 1,201 .00 0
2015-02-12 Sandrock Alfred (Grp SVP, Chief Medical Officer) Option Ex 1,605 .00 0
2015-02-12 Dipietro Kenneth (EVP Human Resources) Option Ex 3,764 .00 0
2015-02-12 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 3,738 .00 0
2015-02-12 Clancy Paul J (Executive VP and CFO) Option Ex 4,299 .00 0
2015-02-12 Kingsley Stuart A (EVP, Global Comm. Operations) Option Ex 3,601 .00 0
2015-02-12 Holtzman Steven H (EVP Corporate Development) Option Ex 3,634 .00 0
2015-02-12 Alexander Susan H (EVP, Chief Legal Officer) Option Ex 3,769 .00 0
2015-02-12 Covino Gregory F (VP, Chief Accounting Officer) Option Ex 471 .00 0
2015-02-12 Scangos George A (Chief Executive Officer) Option Ex 15,599 .00 0
2015-02-12 Williams Douglas E (EVP Research & Development) Option Ex 5,200 .00 0
2015-02-10 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 1,143 398.63 455,630
2015-02-10 Scangos George A (Chief Executive Officer) Option Ex 18,833 .00 0
2015-02-09 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 856 398.05 340,730
2015-02-09 Sandrock Alfred (Grp SVP, Chief Medical Officer) Option Ex 1,824 .00 0
2015-02-09 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 4,691 .00 0
2015-02-09 Clancy Paul J (Executive VP and CFO) Option Ex 4,691 .00 0
2015-02-09 Kingsley Stuart A (EVP, Global Comm. Operations) Option Ex 1,824 .00 0
2015-02-09 Alexander Susan H (EVP, Chief Legal Officer) Option Ex 3,909 .00 0
2015-02-09 Scangos George A (Chief Executive Officer) Option Ex 11,270 .00 0
2015-02-08 Sandrock Alfred (Grp SVP, Chief Medical Officer) Option Ex 1,277 .00 0
2015-02-08 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 4,023 .00 0
2015-02-08 Clancy Paul J (Executive VP and CFO) Option Ex 3,191 .00 0
2015-02-08 Kingsley Stuart A (EVP, Global Comm. Operations) Option Ex 2,636 .00 0
2015-02-08 Holtzman Steven H (EVP Corporate Development) Option Ex 2,705 .00 0
2015-02-08 Alexander Susan H (EVP, Chief Legal Officer) Option Ex 2,498 .00 0
2015-02-08 Williams Douglas E (EVP Research & Development) Option Ex 3,468 .00 0
2015-02-02 Dipietro Kenneth (EVP Human Resources) Sale 1,656 389.03 644,233
2015-02-01 Dipietro Kenneth (EVP Human Resources) Option Ex 2,463 .00 0
2015-02-01 Holtzman Steven H (EVP Corporate Development) Option Ex 5,157 .00 0
2015-02-01 Williams Douglas E (EVP Research & Development) Option Ex 5,157 .00 0
2014-12-15 Artavanis-tsakonas Spyridon (SVP, Chief Scientific Officer) Sale 1,981 346.50 686,416
2014-12-04 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 440 345.88 152,187
2014-12-02 Holtzman Steven H (EVP Corporate Development) Sale 1,749 335.65 587,051
2014-11-11 Holtzman Steven H (EVP Corporate Development) Sale 1,750 330.00 577,500
2014-11-03 Scangos George A (Chief Executive Officer) Sale 1,128 320.78 361,839
2014-10-01 Holtzman Steven H (EVP Corporate Development) Sale 1,750 330.97 579,197
2014-10-01 Scangos George A (Chief Executive Officer) Sale 1,127 330.97 373,003
2014-09-02 Scangos George A (Chief Executive Officer) Sale 1,128 345.47 389,690
2014-08-01 Scangos George A (Chief Executive Officer) Sale 1,128 332.93 375,545
2014-07-16 Scangos George A (Chief Executive Officer) Sale 12,316 312.37 3,847,148
2014-07-15 Scangos George A (Chief Executive Officer) Option Ex 21,339 .00 0
2014-06-20 Posner Brian S (Director) Sale 605 315.00 190,575
2014-06-13 Posner Brian S (Director) Sale 700 310.50 217,350
2014-06-02 Scangos George A (Chief Executive Officer) Sale 484 318.93 154,362
2014-05-19 Holtzman Steven H (EVP Corporate Development) Sale 1,221 289.15 353,052
2014-05-01 Covino Gregory F (VP, Chief Accounting Officer) Option Ex 347 286.75 99,502
2014-05-01 Scangos George A (Chief Executive Officer) Sale 2,123 285.60 606,322
2014-04-17 Holtzman Steven H (EVP Corporate Development) Sale 1,221 291.00 355,311
2014-04-02 Artavanis-tsakonas Spyridon (SVP, Chief Scientific Officer) Option Ex 975 .00 0
2014-04-01 Pangia Robert W (Director) Sale 6,250 308.42 1,927,625
2014-04-01 Pangia Robert W (Director) Option Ex 6,250 47.55 297,187
2014-04-01 Scangos George A (Chief Executive Officer) Sale 2,123 308.42 654,775
2014-03-31 Posner Brian S (Director) Sale 3,000 298.06 894,165
2014-03-20 Dorsa Caroline (Director) Sale 10,000 348.96 3,489,630
2014-03-20 Dorsa Caroline (Director) Option Ex 10,000 53.64 536,400
2014-03-19 Williams Douglas E (EVP Research & Development) Sale 3,505 352.29 1,234,776
2014-03-17 Holtzman Steven H (EVP Corporate Development) Sale 1,221 334.83 408,827
2014-03-11 Kingsley Stuart A (EVP, Global Comm. Operations) Sale 8,428 336.87 2,839,165
2014-03-10 Leaming Nancy (Director) Sale 2,000 327.65 655,300
2014-03-10 Scangos George A (Chief Executive Officer) Sale 26,124 332.92 8,697,097
2014-03-04 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 3,171 342.58 1,086,321
2014-03-03 Scangos George A (Chief Executive Officer) Sale 2,942 335.79 987,894
2014-02-26 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 1,048 342.17 358,594
2014-02-23 Sandrock Alfred (Grp SVP, Chief Medical Officer) Option Ex 1,988 .00 0
2014-02-23 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 2,598 .00 0
2014-02-23 Clancy Paul J (Executive VP and CFO) Option Ex 4,280 .00 0
2014-02-23 Alexander Susan H (EVP, Chief Legal Officer) Option Ex 3,821 .00 0
2014-02-18 Holtzman Steven H (EVP Corporate Development) Sale 1,222 327.90 400,693
2014-02-13 Dipietro Kenneth (EVP Human Resources) Sale 1,290 316.81 408,684
2014-02-13 Scangos George A (Chief Executive Officer) Sale 486 316.81 153,969
2014-02-12 Artavanis-tsakonas Spyridon (SVP, Chief Scientific Officer) Option Ex 714 .00 0
2014-02-12 Dipietro Kenneth (EVP Human Resources) Option Ex 2,246 .00 0
2014-02-12 Cox John (EVP Pharmaceutical Oper & Tech) Option Ex 2,246 .00 0
2014-02-12 Clancy Paul J (Executive VP and CFO) Option Ex 2,807 .00 0
2014-02-12 Kingsley Stuart A (EVP, Global Comm. Operations) Option Ex 2,246 .00 0
2014-02-12 Holtzman Steven H (EVP Corporate Development) Option Ex 2,142 .00 0
2014-02-12 Alexander Susan H (EVP, Chief Legal Officer) Option Ex 2,142 .00 0
2014-02-12 Covino Gregory F (VP, Chief Accounting Officer) Option Ex 315 .00 0
2014-02-12 Scangos George A (Chief Executive Officer) Option Ex 9,189 .00 0
2014-02-12 Williams Douglas E (EVP Research & Development) Option Ex 3,573 .00 0
2014-02-11 Sandrock Alfred (Grp SVP, Chief Medical Officer) Sale 2,085 314.31 655,336
Go to page:  1   2   3   4   5 

Insider trading activities including stock purchases, stock sales, and option exercises of BIIB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biogen Idec Inc (symbol BIIB, CIK number 875045) see the Securities and Exchange Commission (SEC) website.